AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
HUMAN INSULIN
29 registrations across 4 African markets— 29 active
Markets with HUMAN INSULIN
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Humulin N Suspension For Injection | 🇰🇪Kenya | Eli Lilly Exports S.A | active | May 2031 |
| Humulin 70/30 Suspension For Injection | 🇰🇪Kenya | Eli Lilly Exports S.A | active | Mar 2031 |
| INSULATARD 100IU/ML SOLUTION FOR INJECTION IN VIAL (HUMAN INSULIN) | 🇬🇭Ghana | — | active | Jan 2031 |
| ACTRAPID 100IU/ML SOLUTION FOR INJECTION IN VIAL (HUMAN INSULIN) | 🇬🇭Ghana | — | active | Jan 2031 |
| MIXTARD 100IU/ML SUSPENSION FOR INJECTION IN VIAL (HUMAN INSULIN) | 🇬🇭Ghana | — | active | Jan 2031 |
| HUMAN INSULIN PARENTERAL
ORDINARY PRE-
FILLED PENS | 🇺🇬Uganda | NOVO NORDISK | active | — |
| HUMODAR R 100R Solution for injection | 🇹🇿Tanzania | MORAF PHARMACEUTICALS LTD | active | — |
| ACTRAPID Injection | 🇹🇿Tanzania | Novo Nordisk A/S | active | — |
| GENSULIN R Solution for injection | 🇹🇿Tanzania | BIOTON S.A | active | — |
| HUMAN INSULIN PARENTERAL
ORDINARY S C VIALS | 🇺🇬Uganda | ELI-LILLY (SUISSE) SA | active | — |
| Insulatard Flexpen Suspension for injection | 🇹🇿Tanzania | Novo Nordisk A/S | active | — |
| HUMAN INSULIN PARENTERAL
ORDINARY S C
VIALS | 🇺🇬Uganda | ELI-LILLY (SUISSE) SA | active | — |
| GENSULIN M30 (30/70) Suspension for injection | 🇹🇿Tanzania | BIOTON S.A | active | — |
| HUMAN INSULIN | 🇺🇬Uganda | ELI-LILLY (SUISSE) SA | active | — |
| HUMAN INSULIN PARENTERAL
ORDINARY S C
VIALS | 🇺🇬Uganda | ELI-LILLY (SUISSE) SA | active | — |
| HUMAN INSULIN | 🇺🇬Uganda | NOVO NORDISK | active | — |
| HUMAN INSULIN | 🇺🇬Uganda | ELI-LILLY (SUISSE) SA | active | — |
| HUMAN INSULIN PARENTERAL
ORDINARY PRE-
FILLED PENS | 🇺🇬Uganda | NOVO NORDISK | active | — |
| GENSULIN M30 (30/70) Suspension for injection | 🇹🇿Tanzania | BIOTON S.A | active | — |
| Wosulin-30/70 Solution for injection | 🇹🇿Tanzania | Wockhardt Limited | active | — |
| Biosulin R Liquid | 🇹🇿Tanzania | M.J BIOPHARM PRIVATE LIMITED | active | — |
| Wosulin-N Solution for injection | 🇹🇿Tanzania | Wockhardt Limited | active | — |
| HUMAN INSULIN PARENTERAL
ORDINARY S C VIALS | 🇺🇬Uganda | ELI-LILLY (SUISSE) SA | active | — |
| GENSULIN N Suspension for injection | 🇹🇿Tanzania | BIOTON S.A | active | — |
| MIXTARD 30 Suspension for injection | 🇹🇿Tanzania | Novo Nordisk A/S | active | — |
| Jusline N Injection | 🇹🇿Tanzania | Gulf Pharmaceutical Industries-Julphar | active | — |
| Wosulin-R Injection | 🇹🇿Tanzania | Wockhardt Limited | active | — |
| HUMAN INSULIN | 🇺🇬Uganda | NOVO NORDISK | active | — |
| Biosulin N Liquid | 🇹🇿Tanzania | M.J BIOPHARM PRIVATE LIMITED | active | — |
HUMAN INSULIN in Africa — Regulatory Overview
HUMAN INSULIN is registered across 4 African markets with 29 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tanzania, Uganda, Ghana, Kenya. AfricaRegulatory refreshes this data daily from official government sources.
Of the 29 registrations, 29 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.